Literature DB >> 23206861

Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.

Giorgio Ortar1, Luciano De Petrocellis, Aniello Schiano Moriello, Marco Allarà, Enrico Morera, Marianna Nalli, Vincenzo Di Marzo.   

Abstract

A series of twenty-five derivatives of tetrahydro-β-carbolines 1-3 was synthesized and assayed on FAAH and TRPV1 and TRPA1 channels. Four carbamates, that is, 5a,c,e, and 9b inhibited FAAH with significant potency and interacted also effectively with TRPV1 and TRPA1 nociceptive receptors, while ureas 7b,d,f, and 8a,b were endowed with specific submicromolar TRPV1 modulating activities.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206861     DOI: 10.1016/j.bmcl.2012.10.137

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels.

Authors:  Luciano De Petrocellis; Aniello Schiano Moriello; Gabriele Fontana; Alessandro Sacchetti; Daniele Passarella; Giovanni Appendino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.

Authors:  Tyler M Rose; Christopher A Reilly; Cassandra E Deering-Rice; Clinton Brewster; Chelsea Brewster
Journal:  Bioorg Med Chem Lett       Date:  2014-10-28       Impact factor: 2.823

3.  Inhibitory effect of a callophycin A derivative on iNOS expression via inhibition of Akt in lipopolysaccharide-stimulated RAW 264.7 cells.

Authors:  Eun-Jung Park; Li Shen; Dianqing Sun; John M Pezzuto
Journal:  J Nat Prod       Date:  2013-12-03       Impact factor: 4.050

4.  A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway.

Authors:  Fujun Dai; Yihua Chen; Li Huang; Jinhua Wang; Tao Zhang; Jingjie Li; Weiguang Tong; Mingyao Liu; Zhengfang Yi
Journal:  J Cell Mol Med       Date:  2014-10-29       Impact factor: 5.310

Review 5.  Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management.

Authors:  Natalia Malek; Katarzyna Starowicz
Journal:  Front Pharmacol       Date:  2016-08-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.